TG THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 16455995, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2012-12-31) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:07.501658+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/783b43a5-a6b5-4fda-aaaf-94974ef80a0e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-13-016691Retrieved: 2026-08-19T09:42:07.501658+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cash-and-equivalents/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/783b43a5-a6b5-4fda-aaaf-94974ef80a0e
History
- no predecessors — first report